PLRX Q3 2023 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PLRXPliant Therapeutics, Inc.

$82M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$48M

Net Income

-$41M

EPS (Diluted)

$-0.70

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$36M

Free Cash Flow

-$36M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$540M

Total Liabilities

$37M

Stockholders' Equity

$503M

Cash & Equivalents

$58M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$1M	-100.0%
Gross Profit	$0	$1M	-100.0%
Operating Income	-$48M	-$32M	-49.3%
Net Income	-$41M	-$31M	-35.5%